APP and neuroblastoma: To validate the efficacy of BACE1 inhibition, Aβ42 (a BACE cleavage product of APP) was measured in the SK-N-BE(2) neuroblastoma cell model, and sFlag-V5-hSEZ6 and endogenous sSEZ6L in MIN6 cells.